Liposomes and others nanoparticles as the drug delivery systems

Voprosy Meditsinskoj Khimii

Volumn 45, Issue 1, 1999, Pages 11-12

  Kaplun, A P ^a   Le Bang Son, ^a   Krasnopolsky, Yu M ^b   Shvets, V I ^a  

^a MIREA RUSSIAN TECHNOLOGICAL UNIVERSITY   (Russian Federation)

^b Biolek Factory   (Ukraine)

Author keywords

Antitumor and antibacterials; Drug delivery systems; Gene therapy; Liposomes; Nanoparticles; Passive targeting; Vaccine

Indexed keywords

LIPOSOME;

ANIMAL; DRUG DELIVERY SYSTEM; HUMAN; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES;

EID: 0032612301     PISSN: 00428809     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Gregoriadis. G. (1995) TIBECH. 13, 527-537.
2. Yurasov V. V., Kucheryanu V. G.,. Kryzhanovsky G.N,. et al. (1996) Progress in Drug Delivery Systems. Biomedical Research Foundation, Tokyo. Eds. Sadao Hirota, 5, 171-174.
3. Kucheryanu V. G., Yurasov V. V., Kryzhanovsky G. N., et al. (1996) Progress in Drug Delivery Systems. Biomedical Research Foundation, Tokyo, Eds. Sadao Hirota, 5, 179-182.
4. Maeda H., Matsumura Y. (1989) Crit. Rev. Ther. Drug Carrier Syst., 6, 193-210.
5. Seymour L. V. (1992) Crit. Rev. Ther. Drug Carrier Syst. 6, 135-187.
6. Jain R. K. (1987) Cancer Metastasis Rev. 6, 559-593.
7. Huang S.K., Mayhew E., Lasic D.D., et al. (1992) Cancer Res. 52, 6774-6781.
8. Janoff A.S. (1992) Lab. Invest. 66, 655-658.
9. Gabizon A., Catane R., Uziely B., et al. (1994) Cancer Res. 54, 987-992.
10. Gill P.S., Espina B.M., Muggia F., et al. (1995) J. Clin. Oncol. 13, 996-1003.
11. Forssen E.A., Ross M.E. (1994) J. Lipisomes Res. 4, 481-512.
12. Northfelt D.W., Kaplan L., Russell J., et al. (1995) in Stealth Liposomes (Lasic D.D., Martin F.J., eds). 257-266. CRC Press.
13. Bogner J. R., Goebl F-D. (1995) in Stealth Liposomes (Lasic D.D., Martin F.J., eds). CRC Press. 267-278.
14. Blum G., Cevc G. (1990) Biochim. Biophys. Acta, 1029, 91-97.
15. Klibanov A.L., Maruyama K., Torchilin V.V., Huang L. (1990) FEBS Letters., 268, 235-237.
16. Senior J., Delgado C., Fisher D., et al. (1991) Biochim. Biophys. Acta. 1062, 77-82.
17. Papahadjopouluos D., Allen T.M., Gabizon A., et al. (1991) Proc. Natl. Acad. Sci. USA. 88, 11460-11464.
18. Allen T.M., Hansen C. (1991) Biochim. Biophys. Acta. 1068, 133-141.
19. Torchilin V.P., Omelyanenko V.G., Papisov M.I., et al. (1994) Biochim. Biophys. Acta, 1195, 11-20.
20. Torchilin V.P., Shtilman M.I., Trubetskoy V.S., et al. (1994) Biochim Biophys Acta, 1195, 181-184.
21. Gluck R. (1995) In Vaccine Design: The Submit and Adjuvant Approch (Powell M.F., Newman M.J., eds)., Plenum Press. P. 325-345.
22. Le Bang Son, Kaplun A.P., Symon A.V., et al. (1998) J. Liposome Research. 8, 78.
23. Torchilin V.P. (1998) J. Microencapsul, 15, 1-19.
24. Muller R.H., Ruhl D., Runge S., et al. (1997) Pharm. Res. 14 458-462.
25. Yuan F. (1998) Semin. Radiat. Oncol. 8, 164-175.
26. Wiedmann T. S. DeCastro L. Wood R.W. (1997) Pharm. Res. 14, 112-116.
27. Muller R.H., Peters K., Becker R., Kruss B. (1996) Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 22, 574-575.
28. Bohm B.H.L., Grau M.J., Hildebrand G.E., et al. (1998) Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 25, 956-957.
29. Allen T.M. (1997) Drugs, 54, Suppl. 4, P. 8-14.
30. Torchilin V.P. (1996) Mol. Med. Today, 2, 242-249.
31. Torchilin V.P. (1996) J. Mol. Recognit. 9, 335-346.
32. Dass C.R., Walker T.L., Burton M.A., Decruz E.E. (1997) J. Pharm. Pharmacol. 49, 972-975.
33. Alico S.F. (1997) Biochem. Pharmacol. 54, 9-13.
34. Yang K., Clifton G.L., Hayes R.L. (1997) J. Neurotrauma. 14, 281-297.
35. Hirnle P. (1997) Hybridoma. 16, 127-132.
36. Rongen H.A., Bult A., van Bennekom W.P. (1997) J. Immunol. Methods. 204, 105-133.
37. Devine D. V., Marjan J.M. (1997) Crit. Rev. Ther. Drug Carrier Syst. 14, 105-131.
38. Imai E., Isaka Y., Akagi Y., Kaneda Y. (1997) Exp. Nephrol. 5, 112-117.
39. Morishita R., Higaki J., Aoki M., et al. (1996) Contrib. Nephrol. 118, 254-264.
40. Schmid M.H., Korting H.C. (1994) Crit. Rev. in Ther. Drug Carrier Syst., 11, 97-118.
41. Sharata H.H., Katz K.H. (1996) Int. J. Dermatol., 35, 761-769.
42. Cevc G., Crit. Rev. (1996) Ther. Drug Carrier Syst., 13, 257-388.